Movano Health Closes $24 Million Private Placement

TW's Take: Great news for MOVE as they needed cash and this is a nice endorsement by insiders and a quality strategic. Financing included...

Movano Health Announces Over $1M Black Friday Holiday Launch Results for the Evie Ring...

TW's Take: good to see this finally coming to market. I await glucose monitoring before I get too excited, however. PLEASANTON, Calif., Nov. 29, 2023 /PRNewswire/ -- Movano...

Movano Health Announces Closing of $4.1 Million Public Offering Including Full Exercise of Over-Allotment...

TW's Take: much needed capital but this company remains very capital constrained. PLEASANTON, Calif., Nov. 17, 2023 /PRNewswire/ -- Movano Health (Nasdaq: MOVE) ("Movano Health" or...

Movano Health’s Proprietary Chip and Prototype Achieves Accuracy Commensurate with the FDA’s Requirements for...

TW's Take: good news as they are working towards a solution for blood pressure in their Evie Ring, but still quite a ways off. ...

Evie Ring Establishes Medical Advisory Board Furthering its Commitment to Bringing a Medical-Grade Wearable...

The women-led board will leverage their medical and scientific expertise to enhance Evie's product roadmap and provide trusted content PLEASANTON, Calif., Aug. 10, 2023 /PRNewswire/ -- Today, Movano...

Movano Health Prices $8.0 Million Public Offering

TW's Take: needed breathing room in front of some major upcoming catalysts. PLEASANTON, Calif., June 13, 2023 -- Movano Health (Nasdaq: MOVE) ("Movano Health" or the "Company"), a...

Movano Health Provides Business Update and Reports Fourth Quarter 2022 Financial Results

TW's Take: we greatly look forward to the results from the glucose monitoring tests that are due to start "imminently". PLEASANTON, Calif., March 20, 2023 /PRNewswire/ --...

Movano Health Awarded Three New Core Patents Validating its Cutting-Edge Approach to Radio Frequency-Enabled...

TW's Take: the key line from this PR is that the SoC is being tested on patients in this current month of March. Those...

What Women Want: Accuracy is Critical to Future Wearable Use

TW's Take: Movano is positioning themselves well in this market with potentially best in class performance and FDA approval driving adoption. PLEASANTON, Calif., March 7, 2023 /PRNewswire/...

Movano Health Prices $6.5 Million Public Offering

TW's Take: positive to get some financing done which should allow the company to achieve key milestones without additional financing. The biggest risk to...

Movano Health Unveils Evie: First Medical Grade Smart Ring Designed Uniquely for Women

TW's Take: if they can get FDA approved, will be a key differentiation versus the competition. Movano is significantly undervalued relative to peers and...

Movano Health On Track to File First FDA Submission for its Smart Ring’s SpO2...

TW's Take: The data the company has generated is strong enough that one can see them having an FDA approved device, which would be...

Movano Health Announces Launch of Smart Ring Beta Program with Novant Health

TW's Take: Movano is moving forward on their commercial launch, expected to be formally introduced at CES in January. WINSTON-SALEM, N.C. and PLEASANTON, Calif., Dec. 13, 2022 --...

Movano Expands Go-To-Market Team with Vice President of UX and UI and Vice President...

TW's Take: building out the go-to-market team. All systems go as we await the game-changing glucose monitoring data later this year. PLEASANTON, Calif., Aug. 11, 2022 /PRNewswire/...

Movano Ring Exceeds Accuracy Targets for SpO2 and Heart Rate Monitoring in Initial Hypoxia...

TW's Take: Movano is executing on their plan to bring industry-leading technology to market at a reasonable cost. Their data continually achieves best in...

Movano Successfully Completes Functional Testing of Smallest Ever Custom mmWave Sensor Designed for Non-Invasive...

TW's Take: another positive step for Movano as they look poised to become the leaders in non-invasive glucose monitoring.  PLEASANTON, Calif., May 12, 2022 /PRNewswire/ -- Movano Inc. (Nasdaq:...

Movano Hires Chief Marketing Officer to Implement Its Multi-Channel Marketing Strategy for the Movano...

TW's Take: Movano continues to position the company in advance of their products becoming available to the market. PLEASANTON, Calif., April 18, 2022 /PRNewswire/ -- Movano Inc. (Nasdaq: MOVE),...

Movano Inc. Provides Business Update and Reports Fourth Quarter 2021 Financial Results

TW's Take: continued progress including being on schedule with the single chip solution is excellent news. Stock remains a binary play on RF glucose...

Movano Completes its Second Glucose Pilot Study

TW's Take: Movano's unique glucose monitoring technology is the key to this company. We look forward to hearing the results from this sometime in...

Movano Announces Two Key Hires to Further Its Go-To-Market Strategy for the Movano Ring...

TW's Take: solid new hires with great backgrounds will help the launch of new products but also provides nice insider validation of the technology...

Movano Completes Blood Pressure Study with 110 Participants

TW's Take: Movano continues to progress towards development of an industry-leading health monitoring device. The glucose study in Q2 is very exciting as that...

Happy New Year!!!

Investing in micro-cap stocks with a 3-5 year time horizon, which is my expectation for a holding period every time I enter a position,...

Movano Unveils Smart Ring Designed for Women Seeking More Approachable Health Insights

TW's Take: Movano looks ready to exit stealth mode. We are big believers in the future of wearable medical technology and feel that Movano...
DFC Advisory Services LLC (dba TW Research Group) is an investment adviser. We are also compensated for publishing information on certain companies. Information presented is for educational purposes only and does not intend to make an offer or solicitation for the sale or purchase of any specific securities, investments, or investment strategies. Investments involve risk and unless otherwise stated, are not guaranteed. Be sure to first consult with a qualified financial adviser and/or tax professional before implementing any strategy discussed herein. Past performance is not indicative of future performance.